D-1437-2012 Class II Terminated
FDA drug recall D-1437-2012 was initiated by West-Ward Pharmaceutical Corp. on Apr 13, 2012 and is designated Class II. Reason for recall: Presence of Particulate Matter: This product is being recalled due to the discovery of particles in the stability samples and retain samples. The recall status is terminated (terminated Jan 16, 2015). Affected quantity: a) 308,275 vials; b) 2,008,850 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 8, 2012
- Initiation Date
- Apr 13, 2012
- Termination Date
- Jan 16, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- a) 308,275 vials; b) 2,008,850 vials
Product description
Fosphenytoin Sodium Injection, USP, 100 mg PE per 2 mL (50 mg PE per mL), 2 mL Single Dose Vial, packaged in 25-count x 2 mL Single Dose Vials per carton, Rx only, Mfd. By: Hikma Farmaceutica (Portugal), S.A.; Dist. By: West-Ward Pharmaceutical Corp., Eatontown, NJ 07724 USA under the labels a) NOVAPLUS (NDC 0143-9704-25), b) West-Ward (NDC 0143-9788-25).
Reason for recall
Presence of Particulate Matter: This product is being recalled due to the discovery of particles in the stability samples and retain samples.
Distribution pattern
All lots were distributed throughout the US.
Code information
Lot #s: a) 113153.1, 113154.1, 113155.1, Exp 05/13; 113248.1, Exp 07/13; b) 103196.1, 103197.1, 103197.2, 103198.1, Exp 07/12; 103317.1, 103318.1, 103319.1, 103345.1, 103345.2, Exp 11/12; 103346.1, 103347.1, 103348.1, 103349.1, 103350.1, Exp 12/12; 113030.1, 113031.1, 113032.1, 113033.1, 113034.1, 113035.1, 113036.1, Exp 01/13; 113245.1, 113246.1, 113247.1, Exp 07/13
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1437-2012
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026